{
  "generated_at": "2026-01-04T09:52:09Z",
  "breakthroughs": {
    "dpyd_ugt1a1_prepare_rct": {
      "pmid": "39641926",
      "pmc_id": "11624585",
      "endpoint": "clinically relevant toxic effects",
      "arms": {
        "control": {
          "all_patients": {
            "n": 311,
            "tox_events": 54,
            "tox_cell": "54 (17.4)"
          },
          "actionable_carriers": {
            "n": 23,
            "tox_events": 8,
            "tox_cell": "8 (34.8)"
          },
          "nonactionable": {
            "n": 288,
            "tox_events": 46
          }
        },
        "intervention": {
          "all_patients": {
            "n": 252,
            "tox_events": 37,
            "tox_cell": "37 (14.7)"
          },
          "actionable_carriers": {
            "n": 17,
            "tox_events": 1,
            "tox_cell": "1 (5.9)"
          },
          "nonactionable": {
            "n": 235,
            "tox_events": 36
          }
        }
      },
      "note": "Derived from Table 2 by subtraction; provides true negative controls (nonactionable) and carrier vs noncarrier event counts."
    },
    "cyp2c19_clopidogrel_outcomes": {
      "overall": {
        "pmid": "40944685",
        "pmc_id": "12673833",
        "population": "overall",
        "endpoint": "symptomatic ischemic stroke/TIA",
        "groups": {
          "extensive_metabolizer": {
            "n": 205,
            "events": 19
          },
          "poor_or_intermediate_metabolizer": {
            "n": 164,
            "events": 33
          }
        },
        "note": "Counts extracted directly from outcome table; provides borderline IM cases and outcome-linked efficacy signal."
      },
      "clopidogrel_treated": {
        "pmid": "40944685",
        "pmc_id": "12673833",
        "population": "clopidogrel-treated",
        "endpoint": "symptomatic ischemic stroke/TIA",
        "groups": {
          "extensive_metabolizer": {
            "n": 106,
            "events": 5
          },
          "poor_or_intermediate_metabolizer": {
            "n": 104,
            "events": 21
          }
        },
        "note": "Counts extracted directly from outcome table; provides borderline IM cases and outcome-linked efficacy signal."
      }
    }
  },
  "why_this_matters": [
    "Adds true outcome-linked negatives (nonactionable genotypes with observed toxicity vs no toxicity).",
    "Adds borderline CYP2C19 intermediate metabolizer efficacy outcomes on clopidogrel.",
    "Supports moving beyond DPYD-only cohorts toward more representative PGx validation."
  ]
}